The Role of the TRIM Family in Lung Cancer Development: An Emerging Player with Therapeutic Potential

Jinxin Li1,2, Yiling Wang1,2, Jinbai Huang1,2

  • 1Nuclear Medicine Department, The First Affiliated Hospital of Yangtze University, Jingzhou, Hubei, 434023, China.

PubMed

Insights

This review details the role of TRIM proteins in lung cancer, acting as oncoproteins or tumor suppressors. It covers their molecular functions, and advances in lung cancer prognosis and therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Lung cancer is a major global health concern, responsible for significant mortality.
  • TRIM proteins, characterized by E3 ubiquitin ligase activity, are crucial regulators of cellular processes.
  • Dysregulation of TRIM proteins contributes to tumorigenesis in various cancers, including lung cancer.

Purpose of the Study:

  • To review the multifaceted roles of TRIM proteins in lung cancer development.
  • To elucidate the molecular mechanisms underlying TRIM protein function in lung cancer.
  • To summarize recent progress in lung cancer prognosis and therapeutic strategies targeting TRIM proteins.

Main Methods:

  • Literature review of studies on TRIM proteins and lung cancer.
  • Analysis of molecular pathways involving TRIM proteins in cancer biology.
  • Synthesis of current research on TRIM-related lung cancer diagnostics and therapeutics.

Main Results:

  • TRIM proteins exhibit dual roles in lung cancer, functioning as oncogenes or tumor suppressors.
  • Specific TRIM proteins influence key cellular processes like apoptosis, immunity, and signaling pathways in lung cancer.
  • Understanding TRIM protein functions provides insights into lung cancer pathogenesis.

Conclusions:

  • TRIM proteins are critical players in lung cancer progression and development.
  • Targeting TRIM proteins offers potential for novel lung cancer therapeutic strategies.
  • Further research into TRIM protein mechanisms can improve lung cancer patient outcomes.